Department of Biomedical Sciences, Korea University College of Medicine, Seoul 02841, Korea.
College of Pharmacy, University of Houston, Houston, TX 77204, USA.
Mol Cells. 2020 Nov 30;43(11):909-920. doi: 10.14348/molcells.2020.0144.
Cytosolic Ca levels ([Ca]) change dynamically in response to inducers, repressors, and physiological conditions, and aberrant [Ca] concentration regulation is associated with cancer, heart failure, and diabetes. Therefore, [Ca] is considered as a good indicator of physiological and pathological cellular responses, and is a crucial biomarker for drug discovery. A genetically encoded calcium indicator (GECI) was recently developed to measure [Ca] in single cells and animal models. GECI have some advantages over chemically synthesized indicators, although they also have some drawbacks such as poor signal-to-noise ratio (SNR), low positive signal, delayed response, artifactual responses due to protein overexpression, and expensive detection equipment. Here, we developed an indicator based on interactions between Ca-loaded calmodulin and target proteins, and generated an innovative GECI sensor using split nano-luciferase (Nluc) fragments to detect changes in [Ca]. Stimulation-dependent luciferase activities were optimized by combining large and small subunits of Nluc binary technology (NanoBiT, LgBiT:SmBiT) fusion proteins and regulating the receptor expression levels. We constructed the binary [Ca] sensors using a multicistronic expression system in a single vector linked via the internal ribosome entry site (IRES), and examined the detection efficiencies. Promoter optimization studies indicated that promoter-dependent protein expression levels were crucial to optimize SNR and sensitivity. This novel [Ca] assay has high SNR and sensitivity, is easy to use, suitable for high-throughput assays, and may be useful to detect [Ca] in single cells and animal models.
细胞质钙离子浓度 ([Ca]) 会动态响应诱导物、抑制剂和生理条件的变化,而异常的 [Ca] 浓度调节与癌症、心力衰竭和糖尿病有关。因此,[Ca] 被认为是细胞生理和病理反应的良好指标,也是药物发现的关键生物标志物。最近开发了一种遗传编码钙指示剂 (GECI) 来测量单细胞和动物模型中的 [Ca]。与化学合成指示剂相比,GECI 具有一些优势,尽管它们也存在一些缺点,例如信噪比 (SNR) 差、阳性信号低、响应延迟、由于蛋白过表达引起的假象反应以及昂贵的检测设备。在这里,我们基于钙结合钙调蛋白与靶蛋白之间的相互作用开发了一种指示剂,并使用分割纳米荧光素酶 (Nluc) 片段生成了一种创新的 GECI 传感器来检测 [Ca] 的变化。通过组合大、小亚基二元技术(NanoBiT,LgBiT:SmBiT)融合蛋白和调节受体表达水平,优化了刺激依赖性荧光酶活性。我们使用内部核糖体进入位点 (IRES) 连接的单个载体中的多顺反子表达系统构建了二元 [Ca] 传感器,并检查了检测效率。启动子优化研究表明,启动子依赖性蛋白表达水平对于优化 SNR 和灵敏度至关重要。这种新型 [Ca] 测定法具有高 SNR 和灵敏度,易于使用,适用于高通量测定,可能有助于检测单细胞和动物模型中的 [Ca]。